Oliver-Med s.r.o.

The outpatient department at Oliver-Med s.r.o. is investigating how the gut microbiota responds to therapeutic interventions during antibiotic therapy for early Lyme borreliosis. The goal is to improve digestive health outcomes for patients receiving antibiotics.

• Probiotic Saccharomyhiptes boulardii impact on gut flora
• Interaction between antibiotics and microbiome in early Lyme disease
• Strategies to preserve digestive function during infection treatment

Research at this Slovakian site supports better management of digestive system disorders through microbiome‑focused studies.

Clinical work in the allergy unit examines the effectiveness of novel allergen extracts for children with allergic rhinoconjunctivitis caused by grass pollen and birch pollen. These studies aim to reduce symptoms and reliance on rescue medication.

• Pediatric grass pollen allergy treatment
• Birch pollen‑induced rhinoconjunctivitis in adolescents
• Long‑term efficacy of allergen immunotherapy

The center’s immune‑focused trials help shape future allergy care for young patients.

In the metabolic clinic, researchers are evaluating new oral agents that aim to lower blood sugar and promote weight loss in individuals with type 2 diabetes, overweight, or obesity. The studies assess dose‑response relationships and overall impact on glycemic control and body weight.

• Dose‑response of emerging therapy on HbA1c
• Weight reduction outcomes in diabetic patients
• Comparative effectiveness versus placebo

Oliver-Med s.r.o.’s metabolic research contributes to advancing treatment options for diabetes and obesity.